Acamprosate
- PMID: 20163323
- DOI: 10.1517/17425251003641975
Acamprosate
Abstract
Importance of the field: Alcohol abuse and dependence are major causes of morbidity and mortality and come with a high societal cost. The illness is notoriously difficult to treat and relapse is a common occurrence. Acamprosate represents an effective addition to the treatment options available for alcohol dependence with a novel mechanism of action.
Areas covered in this review: We review the published acamprosate literature focusing on major and recent comparative clinical trials and meta-analyses. We included all studies found in National Library of Medicine's PubMed database searching on Mesh term: acamprosate excluded animal studies excluding non-English publications, and focusing on efficacy/effectiveness studies. Additionally, we discuss background information on alcohol dependence and acamprosate's putative mechanism of action. Safety and tolerability data are also presented.
What the reader will gain: The reader will gain a better understanding of the role of acamprosate in the treatment of alcohol dependence and find a useful synopsis of the more recently published literature evaluating acamprosate's effectiveness based on what are not always identically defined primary study outcomes.
Take home message: Acamprosate is safe and effective in the maintenance of abstinence from alcohol use/abuse and is most commonly used in combination with nonpharmacologic therapeutic modalities. The effect size ranged from 1.3 to 2 for most of the studies included in this review.
Similar articles
-
The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.Expert Opin Drug Saf. 2010 Jan;9(1):177-88. doi: 10.1517/14740330903512943. Expert Opin Drug Saf. 2010. PMID: 20021295 Review.
-
Acamprosate for the treatment of alcohol dependence.Clin Ther. 2005 Jun;27(6):695-714. doi: 10.1016/j.clinthera.2005.06.015. Clin Ther. 2005. PMID: 16117977 Review.
-
The pharmacological treatment of alcohol dependence: needs and possibilities.Alcohol Alcohol Suppl. 1996 Mar;31(1):55-8. Alcohol Alcohol Suppl. 1996. PMID: 9845038 Review.
-
Acamprosate for the adjunctive treatment of alcohol dependence.Ann Pharmacother. 2003 Jul-Aug;37(7-8):1090-9. doi: 10.1345/aph.1C351. Ann Pharmacother. 2003. PMID: 12841823 Review.
-
The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.Am J Drug Alcohol Abuse. 2008;34(4):449-61. doi: 10.1080/00952990802082198. Am J Drug Alcohol Abuse. 2008. PMID: 18584575
Cited by
-
Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.Ther Clin Risk Manag. 2012;8:45-53. doi: 10.2147/TCRM.S23184. Epub 2012 Feb 1. Ther Clin Risk Manag. 2012. PMID: 22346357 Free PMC article.
-
Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?Addiction. 2013 Feb;108(2):275-93. doi: 10.1111/j.1360-0443.2012.04054.x. Epub 2012 Oct 17. Addiction. 2013. PMID: 23075288 Free PMC article. Review.
-
Safety and efficacy of acamprosate for the treatment of alcohol dependence.Subst Abuse. 2013;6:1-12. doi: 10.4137/SART.S9345. Epub 2013 Jan 31. Subst Abuse. 2013. PMID: 23399877 Free PMC article.
-
Glutamatergic medications for the treatment of drug and behavioral addictions.Pharmacol Biochem Behav. 2012 Feb;100(4):801-10. doi: 10.1016/j.pbb.2011.04.015. Epub 2011 Apr 22. Pharmacol Biochem Behav. 2012. PMID: 21536062 Free PMC article. Review.
-
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.Neurotherapeutics. 2020 Jan;17(1):55-69. doi: 10.1007/s13311-019-00814-4. Neurotherapeutics. 2020. PMID: 31907876 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials